表紙
市場調查報告書

尿失禁:全球臨床實驗趨勢

Urinary Incontinence Global Clinical Trials Review, H1, 2020

出版商 GlobalData 商品編碼 232274
出版日期 內容資訊 英文
訂單完成後即時交付
價格
尿失禁:全球臨床實驗趨勢 Urinary Incontinence Global Clinical Trials Review, H1, 2020
出版日期: 2020年01月14日內容資訊: 英文
簡介

本報告提供尿失禁相關臨床研究之最新趨勢分析,提供您疾病·治療方法概要,及G7與E7各國的臨床實驗狀況,各地區、各階段的進行狀況,有潛力的贊助商,各企業及研究機關的研究進行狀況,有潛力的藥劑比較等資訊。

本報告概要

各地區的臨床實驗情形

  • 各國臨床實驗數量和平均實驗人數
    • 前五名國家的臨床實驗數量; 亞太地區
    • 前五名國家的臨床實驗數量; 歐洲
    • 主要國家的臨床實驗數量; 北美
    • 前五名國家的臨床實驗數量; 中東/非洲地區
    • 前五名國家的臨床實驗數量; 中南美

G7各國的臨床實驗數量:尿失禁臨床實驗數量佔尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

Phase別臨床實驗數量:G7各國

G7各國的臨床實驗數量:Phase別

E7各國的臨床實驗數量:尿失禁臨床實驗數量佔尿生殖器及性荷爾蒙系疾病臨床實驗數量比率

Phase別臨床實驗數量: E7各國

E7各國的臨床實驗數量:Phase別

Phase別臨床實驗數量

  • Phase別的進展中臨床實驗數量

各進展狀況臨床實驗數量

評估項目別臨床實驗數量

一定期間所採用的受驗人數

贊助商類別的臨床實驗數量

有潛力的贊助商

臨床實驗主要參加企業 - 尿失禁治療藥

有潛力的藥劑

臨床實驗簡介的基本資料

附錄

圖表

本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

目錄
Product Code: GDHC6044CTIDB

GlobalData's clinical trial report, "Urinary Incontinence Global Clinical Trials Review, H1, 2020" provides an overview of Urinary Incontinence Clinical trials scenario. This report provides top line data relating to the clinical trials on Urinary Incontinence. Report includes an overview of trial numbers and their average enrollment in top countries conducted across the globe. The report offers coverage of disease clinical trials by region, country (G7 & E7), phase, trial status, end points status and sponsor type. Report also provides prominent drugs for in-progress trials (based on number of ongoing trials). GlobalData Clinical Trial Reports are generated using GlobalData's proprietary database - Pharma eTrack Clinical trials database. Clinical trials are collated from 80+ different clinical trial registries, conferences, journals, news etc across the globe. Clinical trials database undergoes periodic update by dynamic process.

The report enhances the decision making capabilities and helps to create an effective counter strategies to gain competitive advantage.

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Scope

  • The report provides a snapshot of the global clinical trials landscape
  • Report provides top level data related to the clinical trials by Region, Country (G7 & E7), Trial Status, Trial Phase, Sponsor Type and End point status
  • The report reviews top companies involved and enlists all trials (Trial title, Phase, and Status) pertaining to the company
  • The report provides all the unaccomplished trials (Terminated, Suspended and Withdrawn) with reason for unaccomplishment
  • The Report provides enrollment trends for the past five years
  • Report provides latest news for the past three months

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Reasons to buy

  • Assists in formulating key business strategies with regards to investment
  • Helps in identifying prominent locations for conducting clinical trials which saves time and cost
  • Provides top level analysis of Global Clinical Trials Market which helps in identifying key business opportunities
  • Supports understanding of trials count and enrollment trends by country in global therapeutics market
  • Aids in interpreting the success rates of clinical trials by providing a comparative scenario of completed and uncompleted (terminated, suspended or withdrawn) trials
  • Facilitates clinical trial assessment of the indication on a global, regional and country level

Note: Certain sections in the report may be removed or altered based on the availability and relevance of data for the indicated disease.

Table of Contents

List of Tables

List of Figures

  • Report Guidance
  • GlobalData Clinical Trials Report Coverage
  • Clinical Trials by Region
  • Clinical Trials and Average Enrollment by Country
  • Top Five Countries Contributing to Clinical Trials in Asia-Pacific
  • Top Five Countries Contributing to Clinical Trials in Europe
  • Top Countries Contributing to Clinical Trials in North America
  • Top Five Countries Contributing to Clinical Trials in Middle East and Africa
  • Top Five Countries Contributing to Clinical Trials in Central and South America
  • Clinical Trials by G7 Countries: Proportion of Urinary Incontinence to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in G7 Countries
  • Clinical Trials in G7 Countries by Trial Status
  • Clinical Trials by E7 Countries: Proportion of Urinary Incontinence to Genito Urinary System And Sex Hormones Clinical Trials
  • Clinical Trials by Phase in E7 Countries
  • Clinical Trials in E7 Countries by Trial Status
  • Clinical Trials by Phase
  • In Progress Trials by Phase
  • Clinical Trials by Trial Status
  • Clinical Trials by End Point Status
  • Subjects Recruited Over a Period of Time
  • Clinical Trials by Sponsor Type
  • Prominent Sponsors
  • Top Companies Participating in Urinary Incontinence Therapeutics Clinical Trials
  • Prominent Drugs
  • Clinical Trial Profile Snapshots

Appendix

  • Abbreviations
  • Definitions
  • Research Methodology
  • Secondary Research
  • About GlobalData
  • Contact Us
  • Source

List of Tables

  • Urinary Incontinence Therapeutics, Global, Clinical Trials by Region, 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical Trials In Progress by Top Countries, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Asia-Pacific, Top Five Countries, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Europe, Top Five Countries, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, North America, Top Countries, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Middle East and Africa, Top Five Countries, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Central and South America, Top Five Countries, 2020*
  • Proportion of Urinary Incontinence to Genito Urinary System And Sex Hormones Clinical Trials, G7 Countries (%), 2020*
  • Urinary Incontinence Therapeutics, G7 Countries, Clinical Trials by Phase, 2020*
  • Urinary Incontinence Therapeutics, G7 Countries, Clinical Trials by Trial Status, 2020*
  • Proportion of Urinary Incontinence to Genito Urinary System And Sex Hormones Clinical Trials, E7 Countries (%), 2020*
  • Urinary Incontinence Therapeutics, E7 Countries, Clinical Trials by Phase, 2020*
  • Urinary Incontinence Therapeutics, E7 Countries, Clinical Trials by Trial Status, 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical Trials by Phase, 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical Trials In Progress by Phase 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical Trials by Trial Status, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Global, by End Point Status, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Global, Average Enrollment Target Trends, 2014-2018
  • Urinary Incontinence Therapeutics Market, Global, Clinical Trials by Sponsor Type, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Global, Key Sponsors, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Global, Top Companies by Phase, 2020*
  • Urinary Incontinence Therapeutics Clinical Trials, Global, Ongoing Clinical Trials by Prominent Drugs, 2020*

List of Figures

  • Urinary Incontinence Therapeutics, Global, Clinical Trials by Region (%), 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical Trials and Average Enrollment by Top Countries, 2020*
  • Urinary Incontinence Therapeutics, Global, Clinical T